NO20024155L - Fremgangsmåte for fremstilling av fosforotioattriestere - Google Patents
Fremgangsmåte for fremstilling av fosforotioattriestereInfo
- Publication number
- NO20024155L NO20024155L NO20024155A NO20024155A NO20024155L NO 20024155 L NO20024155 L NO 20024155L NO 20024155 A NO20024155 A NO 20024155A NO 20024155 A NO20024155 A NO 20024155A NO 20024155 L NO20024155 L NO 20024155L
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- phosphorothioate esters
- phosphonate
- alcohol
- phosphorothioate
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- RYYWUUFWQRZTIU-UHFFFAOYSA-N Thiophosphoric acid Chemical class OP(O)(S)=O RYYWUUFWQRZTIU-UHFFFAOYSA-N 0.000 title 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 2
- 108091034117 Oligonucleotide Proteins 0.000 abstract 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 230000008878 coupling Effects 0.000 abstract 1
- 239000007822 coupling agent Substances 0.000 abstract 1
- 238000010168 coupling process Methods 0.000 abstract 1
- 238000005859 coupling reaction Methods 0.000 abstract 1
- 239000002777 nucleoside Substances 0.000 abstract 1
- 125000003835 nucleoside group Chemical group 0.000 abstract 1
- -1 phosphorothioate triester Chemical class 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
- 239000011593 sulfur Substances 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
- C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/16—Esters of thiophosphoric acids or thiophosphorous acids
- C07F9/165—Esters of thiophosphoric acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
- C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Luminescent Compositions (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0004889.2A GB0004889D0 (en) | 2000-03-01 | 2000-03-01 | Synthesis of oligonucleotides |
| PCT/GB2001/000764 WO2001064702A1 (fr) | 2000-03-01 | 2001-02-23 | Procede de preparation de triesters de phosphorothioate |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20024155D0 NO20024155D0 (no) | 2002-08-30 |
| NO20024155L true NO20024155L (no) | 2002-10-24 |
Family
ID=9886705
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20024155A NO20024155L (no) | 2000-03-01 | 2002-08-30 | Fremgangsmåte for fremstilling av fosforotioattriestere |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US7022833B2 (fr) |
| EP (1) | EP1272501B1 (fr) |
| JP (1) | JP2003525305A (fr) |
| KR (1) | KR20030032924A (fr) |
| CN (1) | CN1262557C (fr) |
| AT (1) | ATE266037T1 (fr) |
| AU (2) | AU3576601A (fr) |
| BR (1) | BR0108771A (fr) |
| CA (1) | CA2401083A1 (fr) |
| CZ (1) | CZ20022930A3 (fr) |
| DE (1) | DE60103145T2 (fr) |
| DK (1) | DK1272501T3 (fr) |
| ES (1) | ES2220721T3 (fr) |
| GB (1) | GB0004889D0 (fr) |
| HU (1) | HUP0204249A3 (fr) |
| IL (1) | IL151238A0 (fr) |
| MX (1) | MXPA02008530A (fr) |
| NO (1) | NO20024155L (fr) |
| NZ (1) | NZ520778A (fr) |
| PL (1) | PL362067A1 (fr) |
| WO (1) | WO2001064702A1 (fr) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9717158D0 (en) * | 1997-08-13 | 1997-10-22 | King S College London | Solution synthesis of oligonucleotides and their phosphorothioate analogues |
| WO2003045969A1 (fr) * | 2001-11-21 | 2003-06-05 | Avecia Biotechnology Inc. | Reactif de couplage en chimie des h-phosphonates |
| EP1386925A1 (fr) | 2002-07-31 | 2004-02-04 | Girindus AG | Procédé de préparation des oligonucleotides |
| GB0229423D0 (en) * | 2002-12-18 | 2003-01-22 | Avecia Ltd | Process |
| SG171914A1 (en) | 2008-12-02 | 2011-07-28 | Chiralgen Ltd | Method for the synthesis of phosphorus atom modified nucleic acids |
| EP2451461A4 (fr) | 2009-07-06 | 2013-05-29 | Ontorii Inc | Nouveaux précurseurs d'acide nucléique et leurs méthodes d'utilisation |
| US10428019B2 (en) | 2010-09-24 | 2019-10-01 | Wave Life Sciences Ltd. | Chiral auxiliaries |
| DK2734208T3 (en) * | 2011-07-19 | 2017-06-19 | Wave Life Sciences Ltd | PROCEDURES FOR SYNTHESIS OF FUNCTIONALIZED NUCLEIC ACIDS |
| BR112015000723A2 (pt) | 2012-07-13 | 2017-06-27 | Shin Nippon Biomedical Laboratories Ltd | adjuvante de ácido nucléico quiral |
| ES2862073T3 (es) | 2012-07-13 | 2021-10-06 | Wave Life Sciences Ltd | Grupo auxiliar asimétrico |
| SG11201500232UA (en) | 2012-07-13 | 2015-04-29 | Wave Life Sciences Pte Ltd | Chiral control |
| EP3095459A4 (fr) | 2014-01-15 | 2017-08-23 | Shin Nippon Biomedical Laboratories, Ltd. | Adjuvant d'acide nucléique chiral ayant un effet antitumoral et agent antitumoral |
| EP3095460A4 (fr) | 2014-01-15 | 2017-08-23 | Shin Nippon Biomedical Laboratories, Ltd. | Adjuvant d'acide nucléique chiral ayant une activité anti-allergique, et agent anti-allergique |
| US10144933B2 (en) | 2014-01-15 | 2018-12-04 | Shin Nippon Biomedical Laboratories, Ltd. | Chiral nucleic acid adjuvant having immunity induction activity, and immunity induction activator |
| WO2015107425A2 (fr) | 2014-01-16 | 2015-07-23 | Wave Life Sciences Pte. Ltd. | Conception chirale |
| US20230192751A1 (en) * | 2020-06-02 | 2023-06-22 | The Royal Institution For The Advancement Of Learning/Mcgill University | Method for the preparation of oligonucleotides |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9501465D0 (en) | 1995-01-25 | 1995-03-15 | King S College London | Nucleoside phosphorothioate derivatives,synthesis and use thereof |
| US6096881A (en) * | 1997-05-30 | 2000-08-01 | Hybridon, Inc. | Sulfur transfer reagents for oligonucleotide synthesis |
| GB9717158D0 (en) | 1997-08-13 | 1997-10-22 | King S College London | Solution synthesis of oligonucleotides and their phosphorothioate analogues |
| GB9924285D0 (en) | 1999-10-14 | 1999-12-15 | Avecia Ltd | Process |
-
2000
- 2000-03-01 GB GBGB0004889.2A patent/GB0004889D0/en not_active Ceased
-
2001
- 2001-02-23 EP EP01907898A patent/EP1272501B1/fr not_active Expired - Lifetime
- 2001-02-23 KR KR1020027011442A patent/KR20030032924A/ko not_active Application Discontinuation
- 2001-02-23 ES ES01907898T patent/ES2220721T3/es not_active Expired - Lifetime
- 2001-02-23 MX MXPA02008530A patent/MXPA02008530A/es not_active Application Discontinuation
- 2001-02-23 DK DK01907898T patent/DK1272501T3/da active
- 2001-02-23 AT AT01907898T patent/ATE266037T1/de not_active IP Right Cessation
- 2001-02-23 IL IL15123801A patent/IL151238A0/xx unknown
- 2001-02-23 HU HU0204249A patent/HUP0204249A3/hu unknown
- 2001-02-23 DE DE60103145T patent/DE60103145T2/de not_active Expired - Fee Related
- 2001-02-23 BR BR0108771-1A patent/BR0108771A/pt not_active IP Right Cessation
- 2001-02-23 CZ CZ20022930A patent/CZ20022930A3/cs unknown
- 2001-02-23 JP JP2001564195A patent/JP2003525305A/ja active Pending
- 2001-02-23 PL PL36206701A patent/PL362067A1/xx unknown
- 2001-02-23 WO PCT/GB2001/000764 patent/WO2001064702A1/fr not_active Application Discontinuation
- 2001-02-23 NZ NZ520778A patent/NZ520778A/en unknown
- 2001-02-23 CN CNB018058906A patent/CN1262557C/zh not_active Expired - Fee Related
- 2001-02-23 AU AU3576601A patent/AU3576601A/xx active Pending
- 2001-02-23 CA CA002401083A patent/CA2401083A1/fr not_active Abandoned
- 2001-02-23 AU AU2001235766A patent/AU2001235766B2/en not_active Ceased
- 2001-02-23 US US10/220,353 patent/US7022833B2/en not_active Expired - Lifetime
-
2002
- 2002-08-30 NO NO20024155A patent/NO20024155L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU3576601A (en) | 2001-09-12 |
| NZ520778A (en) | 2004-05-28 |
| GB0004889D0 (en) | 2000-04-19 |
| EP1272501A1 (fr) | 2003-01-08 |
| NO20024155D0 (no) | 2002-08-30 |
| DE60103145T2 (de) | 2005-05-04 |
| EP1272501B1 (fr) | 2004-05-06 |
| AU2001235766B2 (en) | 2005-01-27 |
| US7022833B2 (en) | 2006-04-04 |
| CN1262557C (zh) | 2006-07-05 |
| CZ20022930A3 (cs) | 2002-11-13 |
| HUP0204249A2 (hu) | 2003-04-28 |
| CA2401083A1 (fr) | 2001-09-07 |
| IL151238A0 (en) | 2003-04-10 |
| BR0108771A (pt) | 2002-11-26 |
| CN1406242A (zh) | 2003-03-26 |
| US20030099981A1 (en) | 2003-05-29 |
| DE60103145D1 (de) | 2004-06-09 |
| WO2001064702A1 (fr) | 2001-09-07 |
| JP2003525305A (ja) | 2003-08-26 |
| KR20030032924A (ko) | 2003-04-26 |
| ATE266037T1 (de) | 2004-05-15 |
| PL362067A1 (en) | 2004-10-18 |
| MXPA02008530A (es) | 2003-02-12 |
| DK1272501T3 (da) | 2004-08-16 |
| HUP0204249A3 (en) | 2004-08-30 |
| ES2220721T3 (es) | 2004-12-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20024155L (no) | Fremgangsmåte for fremstilling av fosforotioattriestere | |
| NZ502684A (en) | Solution phase synthesis of phosphorothioate triesters | |
| WO2002018405A3 (fr) | Procede de synthese de nucleosides, de nucleosides en derivant, et de leurs derives non nucleosides | |
| NO20030422D0 (no) | Vaginal avlevering av bisfosfonater | |
| ES2173056T1 (es) | Forma cristalina i de la claritromicina. | |
| AU2203801A (en) | Formulations of adenosine a1 agonists | |
| AU2001250858A1 (en) | Methods of preparing amplified nucleic acid molecules | |
| AU2002217893A1 (en) | Universal supports for oligonucleotide synthesis | |
| AU2001262141A1 (en) | Use of CDP-choline for the treatment of alcohol withdrawal syndrome | |
| AU2001214115A1 (en) | Process for the preparation of anhydrous azithromycin | |
| IT1307383B1 (it) | Giunto elastico per alberi coassiali | |
| WO2000042987A8 (fr) | Produits de recombinaison vesiculaires cibles utilises pour la protection des cellules et le traitement d'infections provoquees par $i(helicobacter pylori) | |
| NO20025703L (no) | Fremgangsmåte for fremstilling av vannfritt natriumperklorat | |
| DE60130391D1 (de) | Behandlungsmittel für Faserprodukte | |
| AU2204001A (en) | Formulations of adenosine a1 agonists | |
| AU2208301A (en) | Formulations of adenosine a1 agonists | |
| AU2001266665A1 (en) | Process for propagation and utilization of mimosa | |
| AU3355600A (en) | Isolation of nucleic acid molecules | |
| SE0003236D0 (sv) | Procedure for treatment of autism by inhibition of post-proline-cleaving enzymes | |
| AU2001215557A1 (en) | Method of designing the molecular structure of inhibitor to enzyme | |
| GB0026494D0 (en) | Isolation of nucleic acid | |
| GB9910158D0 (en) | Isolation of nucleic acid | |
| IT1317829B1 (it) | Processo per la preparazione di cefonicid per via enzimatica. | |
| HU0103642D0 (en) | Process for the preparation of 3-hydroxybenzyl alcohol |